Peptide Information ARA-290 Structure Source PubChem ARA-290 Research ARA-290 is a novel peptide derived from erythropoietin (EPO) that has emerged as a promising therapeutic candidate across multiple disease areas
A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome
Treatment of vitamin B12 and folate deficiencies
Causes of MCAS include: Chronic bacterial infections, such as Lyme disease, Babesia, and Bartonella Chronic viral infections, such as Epstein-Barr Virus and Long COVID Mold illness & fungal infections Heavy metals Environmental toxins, such as herbicides & pesticides SIBO and leaky gut syndrome Allergens food and environmental Genetically predisposed Additionally, certain triggers cause mast cells to degranulate and release mediators in susceptible individuals
Cholera toxin-sensitive GTP-binding protein-coupled activation of augmenter of liver regeneration (ALR) receptor and its function in rat kupffer cells
Using BOTOX with certain other medicines may cause serious side effects